# Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

> **NCT04888338** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 100 (estimated)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm

## Interventions

- **OTHER:** Data Capture
- **OTHER:** Electronic Medical Record

## Key facts

- **NCT ID:** NCT04888338
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-10
- **Primary completion:** 2026-11-14
- **Final completion:** 2026-11-14
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04888338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04888338, "Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04888338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*